Jubilant Pharmova: Can Spokane and radiopharma unlock the next growth phase?
via The Indian Express https://ift.tt/sE0JIgr
The Indian Express
Jubilant Pharmova: Can Spokane and radiopharma unlock the next growth phase?
US sterile injectables, PET radiopharma and CRDMO are reshaping Jubilant Pharmova’s earnings profile. The key question is whether the company can scale its new capacity fast enough to generate returns that justify the significant investment.
September 4, 2026 333 1
